| Line Item | 2025-01-03 | Y/Y |
|---|---|---|
| Revenue | $1.39B | -4.8% |
| Cost of Revenue | $970.3M | -2.9% |
| Gross Profit | $423.6M | -8.9% |
| R&D Expense | $60.3M | +13.4% |
| SG&A Expense | $139.9M | +12.3% |
| Operating Income | $57.7M | -64.0% |
| Interest Expense | $54.9M | +184.4% |
| Pre-tax Income | $1.0M | -99.3% |
| Income Tax | -$5.5M |
| Line Item | 2025-01-03 | Y/Y |
|---|---|---|
| Cash & Equivalents | $71.7M | -14.3% |
| Accounts Receivable | $165.8M | -3.1% |
| Inventory | $404.7M | +8.8% |
| Current Assets | $727.7M | -5.3% |
| Total Assets | $2.23B | -0.4% |
| Current Liabilities | $259.8M | +25.2% |
| Long-term Debt | $552.1M | +47.8% |
| Line Item | 2025-01-03 | Y/Y |
|---|---|---|
| Operating Cash Flow | $131.8M | -26.2% |
| Capital Expenditures | $44.0M | -6.0% |
| Investing Cash Flow | -$76.3M | +89.8% |
| Financing Cash Flow | -$67.3M | -113.2% |
| Free Cash Flow | $87.8M | -33.4% |
| -130.9% |
| Net Income | $6.5M | -94.6% |
| EPS (Basic) | $0.16 | -94.4% |
| EPS (Diluted) | $0.16 | -94.4% |
| Total Liabilities |
| $1.03B |
| +1.0% |
| Stockholders' Equity | $1.20B | -1.7% |